ACC.15.

SCOT-HEART: Coronary angiography by tomography in patients with suspected coronary artery disease

The aim of this study was to evaluate Coronary angiography by multislice CT compared with standard therapy...

OSLER: Evolocumab reduces cardiovascular events compared with standard statin therapy

The aim of this study was to evaluate the safety and efficacy of long-term Evolocumab, an inhibitor...

ODYSSEY LONG TERM: alirocumab reduces LDL in patients with maximum tolerated doses of statins

The aim of this study was to evaluate treatment with alirocumab a monoclonal antibody against PCSK9 receptor,...

NOTION: TAVR in low-risk patients

The aim of this study was to compare the results of transcatheter aortic valve replacement (TAVR) versus...

EMBRACE STEMI: Bendavia a new drug to prevent mitochondrial dysfunction in AMI.

The purpose of this phase 2 study was to test the safety and efficacy of new drug...

CSPPT: folic acid for primary prevention of stroke

The aim of this study was to evaluate the effectiveness of supplementation with folic acid in primary...

PEGASUS-TIMI 54: Ticagrelor plus ASA in stable patients

This double-blind study included 21162 patients with a history of acute myocardial infarction randomized to ticagrelor 90...

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received...